Bellwether Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,040
Closed -$2.52M 254
2023
Q1
$2.52M Buy
5,040
+893
+22% +$427K 0.69% 29
2022
Q4
$1.69M Buy
+4,147
New +$1.61M 0.49% 50
2022
Q3
Sell
-1
Closed 488
2022
Q2
$0 Sell
1
-9
-90% -$3.67K ﹤0.01% 482
2022
Q1
$5K Buy
10
+1
+11% +$526 ﹤0.01% 365
2021
Q4
$5K Hold
9
﹤0.01% 399
2021
Q3
$5K Buy
+9
New +$6.05K ﹤0.01% 366

Other funds holding IDXX

Bellwether Advisors's IDXX Position: Q2 2023 in Review

Bellwether Advisors sold out of Idexx Laboratories (IDXX) in Q2 2023, closing a stake of 5,040 shares — an estimated $2.52M sold.

Bellwether Advisors first reported a position in IDXX in Q3 2021 and held it in 6 quarters. The position peaked at $2.52M in Q1 2023. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

  • Bellwether Advisors reported no remaining Idexx Laboratories position as of Q2 2023 after selling out during the quarter.
  • Bellwether Advisors sold 5,040 Idexx Laboratories shares in Q2 2023, an estimated $2.52M.
  • Bellwether Advisors first reported a position in Idexx Laboratories in Q3 2021 and held it in 6 quarters.
  • Bellwether Advisors's Idexx Laboratories position peaked at $2.52M in Q1 2023.
  • 1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Bellwether Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.